# Prospective Validation of Prostate Biomarkers for Repeat Biopsy

> **NCT03082274** · — · UNKNOWN · sponsor: **MDx Health** · enrollment: 1000 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DIAGNOSTIC_TEST:** ConfirmMDx
- **DIAGNOSTIC_TEST:** SelectMDx

## Key facts

- **NCT ID:** NCT03082274
- **Lead sponsor:** MDx Health
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-03-31
- **Primary completion:** 2019-12-30
- **Final completion:** 2019-12-30
- **Target enrollment:** 1000 (ACTUAL)
- **Last updated:** 2018-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03082274

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03082274, "Prospective Validation of Prostate Biomarkers for Repeat Biopsy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03082274. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*